BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29956121)

  • 1. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
    Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW
    Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating an miR-140-5p binding site.
    Wang M; Du M; Ma L; Chu H; Lv Q; Ye D; Guo J; Gu C; Xia G; Zhu Y; Ding Q; Yuan L; Fu G; Tong N; Qin C; Yin C; Xu J; Zhang Z
    Int J Cancer; 2016 Jul; 139(1):65-74. PubMed ID: 26695686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk.
    Lehmann ML; Selinski S; Blaszkewicz M; Orlich M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Dietrich H; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Löhlein D; Weistenhöfer W; Schöps W; Beg AE; Aslam M; Bánfi G; Romics I; Ickstadt K; Schwender H; Winterpacht A; Hengstler JG; Golka K
    Arch Toxicol; 2010 Dec; 84(12):967-78. PubMed ID: 21063684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription Factor KLF5 Binds a Cyclin E1 Polymorphic Intronic Enhancer to Confer Increased Bladder Cancer Risk.
    Pattison JM; Posternak V; Cole MD
    Mol Cancer Res; 2016 Nov; 14(11):1078-1086. PubMed ID: 27514407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
    Zhu DL; Chen XF; Hu WX; Dong SS; Lu BJ; Rong Y; Chen YX; Chen H; Thynn HN; Wang NN; Guo Y; Yang TL
    J Bone Miner Res; 2018 Jul; 33(7):1335-1346. PubMed ID: 29528523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North Indians.
    Singh V; Jaiswal PK; Mittal RD
    Urol Oncol; 2014 Nov; 32(8):1209-14. PubMed ID: 25218484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
    Jin HJ; Jung S; DebRoy AR; Davuluri RV
    Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".
    Golka K; Selinski S; Lehmann ML; Blaszkewicz M; Marchan R; Ickstadt K; Schwender H; Bolt HM; Hengstler JG
    Arch Toxicol; 2011 Jun; 85(6):539-54. PubMed ID: 21380501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Predisposition to the Mortality in Septic Shock Patients: From GWAS to the Identification of a Regulatory Variant Modulating the Activity of a
    Rosier F; Brisebarre A; Dupuis C; Baaklini S; Puthier D; Brun C; Pradel LC; Rihet P; Payen D
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine Mapping in Chromosome 3q28 Identified Two Variants Associated with Lung Cancer Risk in Asian Population.
    Wen Y; Zhu C; Li N; Li Z; Cheng Y; Dong J; Zhu M; Wang Y; Dai J; Ma H; Jin G; Dai M; Hu Z; Shen H
    J Cancer; 2019; 10(8):1862-1869. PubMed ID: 31205543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating expression-related SNPs into genome-wide gene- and pathway-based analyses identified novel lung cancer susceptibility genes.
    Wang Y; Wu W; Zhu M; Wang C; Shen W; Cheng Y; Geng L; Li Z; Zhang J; Dai J; Ma H; Chen L; Hu Z; Jin G; Shen H
    Int J Cancer; 2018 Apr; 142(8):1602-1610. PubMed ID: 29193083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common predisposition alleles for moderately common cancers: bladder cancer.
    Kiltie AE
    Curr Opin Genet Dev; 2010 Jun; 20(3):218-24. PubMed ID: 20153630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia.
    Hosgood HD; Wang WC; Hong YC; Wang JC; Chen K; Chang IS; Chen CJ; Lu D; Yin Z; Wu C; Zheng W; Qian B; Park JY; Kim YH; Chatterjee N; Chen Y; Chang GC; Hsiao CF; Yeager M; Tsai YH; Wei H; Kim YT; Wu W; Zhao Z; Chow WH; Zhu X; Lo YL; Sung SW; Chen KY; Yuenger J; Kim JH; Huang L; Chen YH; Gao YT; Kim JH; Huang MS; Jung TH; Caporaso N; Zhao X; Huan Z; Yu D; Kim CH; Su WC; Shu XO; Kim IS; Bassig B; Chen YM; Cha SI; Tan W; Chen H; Yang TY; Sung JS; Wang CL; Li X; Park KH; Yu CJ; Ryu JS; Xiang Y; Hutchinson A; Kim JS; Cai Q; Landi MT; Lee KM; Hung JY; Park JY; Tucker M; Lin CC; Ren Y; Perng RP; Chen CY; Jin L; Chen KC; Li YJ; Chiu YF; Tsai FY; Yang PC; Fraumeni JF; Seow A; Lin D; Zhou B; Chanock S; Hsiung CA; Rothman N; Lan Q
    Hum Genet; 2012 Jul; 131(7):1197-203. PubMed ID: 22367405
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Cannon ME; Duan Q; Wu Y; Zeynalzadeh M; Xu Z; Kangas AJ; Soininen P; Ala-Korpela M; Civelek M; Lusis AJ; Kuusisto J; Collins FS; Boehnke M; Tang H; Laakso M; Li Y; Mohlke KL
    G3 (Bethesda); 2017 Sep; 7(9):3217-3227. PubMed ID: 28754724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.
    Wu L; Chaffee KG; Parker AS; Sicotte H; Petersen GM
    Tumour Biol; 2015 Sep; 36(10):7431-7. PubMed ID: 25900876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional Variant (Rs35592567) in TP63 at 3q28 is Associated with Gastric Cancer Risk via Modifying its Regulation by MicroRNA-140.
    Lu C; Yang Y; Ma S
    Cell Physiol Biochem; 2018; 47(1):235-244. PubMed ID: 29763931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Common Type 2 Diabetes Risk Variant Potentiates Activity of an Evolutionarily Conserved Islet Stretch Enhancer and Increases C2CD4A and C2CD4B Expression.
    Kycia I; Wolford BN; Huyghe JR; Fuchsberger C; Vadlamudi S; Kursawe R; Welch RP; Albanus RD; Uyar A; Khetan S; Lawlor N; Bolisetty M; Mathur A; Kuusisto J; Laakso M; Ucar D; Mohlke KL; Boehnke M; Collins FS; Parker SCJ; Stitzel ML
    Am J Hum Genet; 2018 Apr; 102(4):620-635. PubMed ID: 29625024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.
    Stern MC; Van Den Berg D; Yuan JM; Conti DV; Gago-Dominguez M; Pike MC; Xiang YB; Gao YT; Cortessis VK
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3057-61. PubMed ID: 19843673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells.
    López Rodríguez M; Kaminska D; Lappalainen K; Pihlajamäki J; Kaikkonen MU; Laakso M
    Genome Med; 2017 Jul; 9(1):63. PubMed ID: 28683826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.
    Figueroa JD; Middlebrooks CD; Banday AR; Ye Y; Garcia-Closas M; Chatterjee N; Koutros S; Kiemeney LA; Rafnar T; Bishop T; Furberg H; Matullo G; Golka K; Gago-Dominguez M; Taylor JA; Fletcher T; Siddiq A; Cortessis VK; Kooperberg C; Cussenot O; Benhamou S; Prescott J; Porru S; Dinney CP; Malats N; Baris D; Purdue MP; Jacobs EJ; Albanes D; Wang Z; Chung CC; Vermeulen SH; Aben KK; Galesloot TE; Thorleifsson G; Sulem P; Stefansson K; Kiltie AE; Harland M; Teo M; Offit K; Vijai J; Bajorin D; Kopp R; Fiorito G; Guarrera S; Sacerdote C; Selinski S; Hengstler JG; Gerullis H; Ovsiannikov D; Blaszkewicz M; Castelao JE; Calaza M; Martinez ME; Cordeiro P; Xu Z; Panduri V; Kumar R; Gurzau E; Koppova K; Bueno-De-Mesquita HB; Ljungberg B; Clavel-Chapelon F; Weiderpass E; Krogh V; Dorronsoro M; Travis RC; Tjønneland A; Brennan P; Chang-Claude J; Riboli E; Conti D; Stern MC; Pike MC; Van Den Berg D; Yuan JM; Hohensee C; Jeppson RP; Cancel-Tassin G; Roupret M; Comperat E; Turman C; De Vivo I; Giovannucci E; Hunter DJ; Kraft P; Lindstrom S; Carta A; Pavanello S; Arici C; Mastrangelo G; Kamat AM; Zhang L; Gong Y; Pu X; Hutchinson A; Burdett L; Wheeler WA; Karagas MR; Johnson A; Schned A; Monawar Hosain GM; Schwenn M; Kogevinas M; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Andriole G; Grubb R; Black A; Diver WR; Gapstur SM; Weinstein S; Virtamo J; Haiman CA; Landi MT; Caporaso NE; Fraumeni JF; Vineis P; Wu X; Chanock SJ; Silverman DT; Prokunina-Olsson L; Rothman N
    Hum Mol Genet; 2016 Mar; 25(6):1203-14. PubMed ID: 26732427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.